SEC Form 4 · accession 0002147232-26-000006
BioStem Technologies, Inc. · BSEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A Fortunato
Officer — Chief Accounting Officer
Period of report
Aug 9, 2026
Accepted (ET)
Aug 20, 2026 · 7:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001658678
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 9, 2026 | M | 970 | $0.00 | A | 64,430 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF6,F8 | — | Aug 9, 2026 | M | 970 | D | — | — | Common Stock | 970 | 6,790 | D |
| Stock Options (Right to Buy)F1 | $1.07 | holding | — | — | — | — | Aug 16, 2027 | Common Stock | 200,000 | 200,000 | D |
| Stock Options (Right to Buy)F2 | $2.99 | holding | — | — | — | — | Jan 4, 2033 | Common Stock | 100,000 | 100,000 | D |
| Stock Options (Right to Buy)F3 | $15.11 | holding | — | — | — | — | May 9, 2035 | Common Stock | 11,582 | 11,582 | D |
| Stock Options (Right to Buy)F4 | $15.11 | holding | — | — | — | — | Oct 13, 2035 | Common Stock | 2,340 | 2,340 | D |
| Stock Options (Right to Buy)F5 | $5.50 | holding | — | — | — | — | Feb 11, 2036 | Common Stock | 38,546 | 38,546 | D |
| Restricted Stock UnitsF6,F7 | — | holding | — | — | — | — | — | Common Stock | 21,175 | 21,175 | D |
| Restricted Stock UnitsF6,F9 | — | holding | — | — | — | — | — | Common Stock | 31,818 | 31,818 | D |
Explanation of responses
- F1These options are fully vested and exercisable.
- F2These options vest according to the following schedule: 25% vested on January 4, 2024, with the remaining options vesting in equal monthly installments over the subsequent three year period.
- F3These options vest with the following schedule: 33% vested on May 9, 2026, with the remaining options vesting in equal quarterly installment over the subsequent two year period.
- F4These option vest with the following schedule: 33% will vest on October 13, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F5These options vest with the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F6Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F7These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).
- F8These restricted stock units vest according to the following schedule: 33% vested on May 9, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Due to an administrative error, the vesting of the restricted stock units was not timely reported on a Form 4 within two business day of the applicable transaction date.
- F9These restricted stock units vest according to the following schedule: 33% vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.
Remarks
Exhibit 24 - Power of Attorney